Combination Therapy Provides Similar Clinical Benefit as Single Drug Treatment in People with MS
March 11, 2013
Drugs taken together do not reduce risk of relapse but appear to prevent development of new lesions
Facts about How Mount Sinai is Researching and Treating Brain Diseases
December 14, 2012
The Mount Sinai Medical Center is one of the world’s leading institutions in discovering better ways to prevent, diagnose, and treat serious brain diseases.
Mount Sinai Researchers Help Identify Differences in Disease Progression in Two Subtypes of MS
April 14, 2011
New data from the American Academy of Neurology meeting describes the consequences of relapses in MS patients who initially have a progressive course.
Groundbreaking Multiple Sclerosis Research Presented at American Academy of Neurology Annual Meeting
April 13, 2010
Researchers from Mount Sinai School of Medicine will present several studies on multiple sclerosis at the American Academy of Neurology Annual Meeting.
Physicians from the CGD Center Visit Capitol Hill to Lobby for Research Funding; Patient Registry
March 8, 2010
Leaders join National MS Society in visits to local members of Congress to urge passage of key legislation
CGD Center for MS Recognized as an Affiliated MS Comprehensive Care Center by National MS Society
December 31, 2009
CGD Center is one of first in nation to meet new criteria for patient-centered care by multiple health care providers covering a range of needs.
MS Symposium Presented by Corinne Goldsmith Dickinson Center Draws Hundreds Seeking Information and Hope
October 23, 2009
Patient education event covers latest scientific studies, symptom management, and new treatment guidelines.
Fred D. Lublin, MD, Receives $19 Million Grant for MS Clinical Trial
June 17, 2009
CombiRx, a multi-center clinical trial for Multiple Sclerosis (MS) therapeutics, just received a $19-million renewal grant from the National Institutes of Health (NIH).
Aaron E. Miller, MD, Elected to American Academy of Neurology Board
June 1, 2009
Aaron E. Miller, MD, internationally known multiple sclerosis (MS) clinician, has been elected to the Board of Directors of the American Academy of Neurology (AAN).
New Psychiatric Program at The Mount Sinai Medical Center Addresses Special Needs of Multiple Sclerosis Patients
February 26, 2009
The new program provides for an on-site psychiatrist to assist in the identification and management of psychiatric and psychological disorders in patients with MS, including depression.
5 East 98th Street
New York, NY 10029-6574